Mathew N. Hulett - 29 Apr 2024 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 May 2024, 14:26:55 UTC
Prior SEC filing
07 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matt N. Hulett

Key filing fact

Mathew N. Hulett filed Form 4 for PETMED EXPRESS INC (PETS) on 01 May 2024.

Key facts

  • This page summarizes Mathew N. Hulett's Form 4 filing for PETMED EXPRESS INC (PETS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 May 2024, 14:26.

Change

  • Previous filing in this sequence was filed on 07 Nov 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Disposed to Issuer

Transaction value
$0
Shares
-510,000
Change %
-83%
Price
$0.000000
Shares after
103,850
Date
29 Apr 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mathew N. Hulett is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents forfeiture of restricted performance stock granted pursuant to the PetMed Express, Inc.'s 2016 Employee Equity Compensation Restricted Stock Plan on August 30, 2021, as a result of cessation of employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .